A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

Not all supplements are over the counter. Discover which ones require a prescription and the risks of taking high doses.

New findings could partially help explain why some people appear to lose weight more quickly than others while taking the ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

Why do Ozempic and Zepbound work differently for everyone? A new study identifies genetic variants linked to GLP-1 weight loss and side effects.

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...

Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to GLP-1 drugs ...